Explore
Validate
Learn67086-1-Ig
antibody from Proteintech Group
Targeting: RUNX1T1
AML1T1, CBFA2T1, CDR, ETO, MTG8, ZMYND2
Western blotAntibody data
- Antibody Data
- Antigen structure
- References [2]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 67086-1-Ig - Provider product page
- Provider
- Proteintech Group
- Product name
- RUNX1T1 antibody
- Antibody type
- Monoclonal
- Description
- RUNX1T1 antibody (Cat. #67086-1-Ig) is a mouse monoclonal antibody that shows reactivity with Human, mouse, rat, pig and has been validated for the following applications: WB,ELISA.
- Reactivity
- Human, Mouse, Rat, Porcine
- Host
- Mouse
- Conjugate
- Unconjugated
- Isotype
- IgG
- Antibody clone number
- 2G2F7
- Vial size
- 20ul, 150ul
Submitted references USP5 inhibition enables potential therapy for t(8;21) AML through ubiquitin-mediated AML1-ETO degradation in patient-derived xenografts.
Neratinib impairs function of m6A recognition on AML1-ETO pre-mRNA and induces differentiation of t (8;21) AML cells by targeting HNRNPA3.
Ma L, Zhang K, Zhang Z, Wang C, Ma M, Liu Y, Zhao Y, Gong Z, Liu N, Wei M, Liu X, Zhou J, Liu S, Yang C, Yang G
Science translational medicine 2025 Sep 24;17(817):eadt9100
Science translational medicine 2025 Sep 24;17(817):eadt9100
Neratinib impairs function of m6A recognition on AML1-ETO pre-mRNA and induces differentiation of t (8;21) AML cells by targeting HNRNPA3.
Liu Y, Zheng L, Li Y, Ma L, Zheng N, Liu X, Zhao Y, Yu L, Liu N, Liu S, Zhang K, Zhou J, Wei M, Yang C, Yang G
Cancer letters 2024 Jul 10;594:216980
Cancer letters 2024 Jul 10;594:216980
No comments: Submit comment
No validations: Submit validation data